Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Patent
1996-04-08
1998-10-06
Eisenschenk, Frank C.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
4241811, 4241831, 424 149, 435332, 5303888, 5303897, 5303913, 5303917, A61K 39395, C07K 1630
Patent
active
058173137
ABSTRACT:
The invention provides a novel treatment of cancer using a monoclonal antibody that recognizes cell surface antigens present on a number of tumor cells, including ovarian, esophageal and cervical carcinomas. A preferred monoclonal antibody is secreted by a hybridoma deposited with the ATCC and has Accession NO. HB 10570.
REFERENCES:
Waldmann, Science, 252:1657, 1991.
Blattler, Cancer Cells, 1(2):50, 1989.
Riechmann et al., Nature, 332:323, 1988.
Abramowicz et al., New Engl. J. Med., Sep. 3, 1992, p. 736.
Blast et al., J. Clin. Invest., 68:1331, 1981.
Hamilton et al., Cancer Res., 43:5379, 1983.
Chang Kai
Pastan Ira
Willingham Mark C.
Eisenschenk Frank C.
The United States of America as represented by the Secretary of
LandOfFree
Monoclonal antibodies and conjugates thereof useful for the trea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies and conjugates thereof useful for the trea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies and conjugates thereof useful for the trea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-74500